The diagnostics sector is a rapidly evolving part of healthcare, sitting at the crossroads of biotechnology, data science, and clinical practice. It spans a wide range of applications, from oncology and infectious diseases to genetic testing, chronic conditions, and preventive health, with technologies that include molecular assays, imaging, AI-powered software, and digital platforms. In recent years, the field has been transformed by liquid biopsy, next-generation sequencing, and digital diagnostics, enabling earlier detection, personalized treatment, and more accessible point-of-care solutions. At the same time, emerging frontiers like CRISPR-based diagnostics, multi-omics, and wearable biosensors are expanding possibilities for continuous and real-time health monitoring. As healthcare systems move toward precision medicine and proactive care, diagnostics companies are becoming critical enablers, not only for patient outcomes but also for reshaping the economics of healthcare delivery.